-
1
-
-
53249123632
-
-
International Agency for Research on Cancer, and World Health Organization International Agency for Research on Cancer, Lyon, France
-
Swerdlow, S., International Agency for Research on Cancer, and World Health Organization. 2008. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer, Lyon, France.
-
(2008)
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
-
-
Swerdlow, S.1
-
2
-
-
33845935489
-
Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes
-
Germing, U., C. Strupp, A. Kuendgen, S. Isa, S. Knipp, B. Hildebrandt, A. Giagounidis, C. Aul, N. Gattermann, and R. Haas. 2006. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. Haematologica 91: 1596-1604. (Pubitemid 46032956)
-
(2006)
Haematologica
, vol.91
, Issue.12
, pp. 1596-1604
-
-
Germing, U.1
Strupp, C.2
Kuendgen, A.3
Isa, S.4
Knipp, S.5
Hildebrandt, B.6
Giagounidis, A.7
Aul, C.8
Gattermann, N.9
Haas, R.10
-
3
-
-
32144431895
-
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making
-
DOI 10.1200/JCO.2005.01.7038
-
Malcovati, L., M. G. Porta, C. Pascutto, R. Invernizzi, M. Boni, E. Travaglino, F. Passamonti, L. Arcaini, M. Maffioli, P. Bernasconi, et al. 2005. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. J. Clin. Oncol. 23: 7594-7603. (Pubitemid 46291823)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.30
, pp. 7594-7603
-
-
Malcovati, L.1
Della, P.M.G.2
Pascutto, C.3
Invernizzi, R.4
Boni, M.5
Travaglino, E.6
Passamonti, F.7
Arcaini, L.8
Maffioli, M.9
Bernasconi, P.10
Lazzarino, M.11
Cazzola, M.12
-
4
-
-
53149113768
-
Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
-
Kantarjian, H., S. O'Brien, F. Ravandi, J. Cortes, J. Shan, J. M. Bennett, A. List, P. Fenaux, G. Sanz, J. P. Issa, et al. 2008. Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System. Cancer 113: 1351-1361.
-
(2008)
Cancer
, vol.113
, pp. 1351-1361
-
-
Kantarjian, H.1
O'Brien, S.2
Ravandi, F.3
Cortes, J.4
Shan, J.5
Bennett, J.M.6
List, A.7
Fenaux, P.8
Sanz, G.9
Issa, J.P.10
-
5
-
-
53549108334
-
International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: Impact of cytopenias on clinical outcomes in myelodysplastic syndromes
-
Kao, J. M., A. McMillan, and P. L. Greenberg. 2008. International MDS risk analysis workshop (IMRAW)/IPSS reanalyzed: impact of cytopenias on clinical outcomes in myelodysplastic syndromes. Am. J. Hematol. 83: 765-770.
-
(2008)
Am. J. Hematol.
, vol.83
, pp. 765-770
-
-
Kao, J.M.1
McMillan, A.2
Greenberg, P.L.3
-
6
-
-
84860682437
-
Validation of the MD Anderson Prognostic Risk Model for patients with myelodysplastic syndrome
-
Komrokji, R. S., M. Corrales-Yepez, N. Al Ali, M. Kharfan-Dabaja, E. Padron, T. Fields, J. E. Lancet, and A. F. List. 2012. Validation of the MD Anderson Prognostic Risk Model for patients with myelodysplastic syndrome. Cancer 118: 2659-2664.
-
(2012)
Cancer
, vol.118
, pp. 2659-2664
-
-
Komrokji, R.S.1
Corrales-Yepez, M.2
Al Ali, N.3
Kharfan-Dabaja, M.4
Padron, E.5
Fields, T.6
Lancet, J.E.7
List, A.F.8
-
7
-
-
7344223859
-
Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor V(β) profiles
-
DOI 10.1046/j.1365-2141.1998.00920.x
-
Molldrem, J. J., Y. Z. Jiang, M. Stetler-Stevenson, D. Mavroudis, N. Hensel, and A. J. Barrett. 1998. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor Vbeta profiles. Br. J. Haematol. 102: 1314-1322. (Pubitemid 28435218)
-
(1998)
British Journal of Haematology
, vol.102
, Issue.5
, pp. 1314-1322
-
-
Molldrem, J.J.1
Jiang, Y.Z.2
Stetler-Stevenson, M.3
Mavroudis, D.4
Hensel, N.5
Barrett, A.J.6
-
8
-
-
0037031289
-
Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes
-
Molldrem, J. J., E. Leifer, E. Bahceci, Y. Saunthararajah, M. Rivera, C. Dunbar, J. Liu, R. Nakamura, N. S. Young, and A. J. Barrett. 2002. Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes. Ann. Intern. Med. 137: 156-163. (Pubitemid 34827511)
-
(2002)
Annals of Internal Medicine
, vol.137
, Issue.3
, pp. 156-163
-
-
Molldrem, J.J.1
Leifer, E.2
Bahceci, E.3
Saunthararajah, Y.4
Rivera, M.5
Dunbar, C.6
Liu, J.7
Nakamura, R.8
Young, N.S.9
Barrett, A.J.10
-
9
-
-
23044473715
-
Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome
-
DOI 10.1182/blood-2004-05-2017
-
Sloand, E. M., L. Mainwaring, M. Fuhrer, S. Ramkissoon, A. M. Risitano, K. Keyvanafar, J. Lu, A. Basu, A. J. Barrett, and N. S. Young. 2005. Preferential suppression of trisomy 8 compared with normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome. Blood 106: 841-851. (Pubitemid 41076423)
-
(2005)
Blood
, vol.106
, Issue.3
, pp. 841-851
-
-
Sloand, E.M.1
Mainwaring, L.2
Fuhrer, M.3
Ramkissoon, S.4
Risitano, A.M.5
Keyvanafar, K.6
Lu, J.7
Basu, A.8
Barrett, A.J.9
Young, N.S.10
-
10
-
-
78650354414
-
Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions
-
Sloand, E. M., M. J. Olnes, A. Shenoy, B. Weinstein, C. Boss, K. Loeliger, C. O. Wu, K. More, A. J. Barrett, P. Scheinberg, and N. S. Young. 2010. Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions. J. Clin. Oncol. 28: 5166-5173.
-
(2010)
J. Clin. Oncol.
, vol.28
, pp. 5166-5173
-
-
Sloand, E.M.1
Olnes, M.J.2
Shenoy, A.3
Weinstein, B.4
Boss, C.5
Loeliger, K.6
Wu, C.O.7
More, K.8
Barrett, A.J.9
Scheinberg, P.10
Young, N.S.11
-
11
-
-
0037272767
-
Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes
-
DOI 10.1046/j.1365-2141.2003.03907.x
-
Bowen, D., D. Culligan, S. Jowitt, S. Kelsey, G. Mufti, D. Oscier, and J. Parker; UK MDS Guidelines Group. 2003. Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes. Br. J. Haematol. 120: 187-200. (Pubitemid 36194166)
-
(2003)
British Journal of Haematology
, vol.120
, Issue.2
, pp. 187-200
-
-
Bowen, D.1
Culligan, D.2
Jowitt, S.3
Kelsey, S.4
Mufti, G.5
Oscier, D.6
Parker, J.7
-
12
-
-
0033168037
-
Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody
-
Onizuka, S., I. Tawara, J. Shimizu, S. Sakaguchi, T. Fujita, and E. Nakayama. 1999. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res. 59: 3128-3133. (Pubitemid 29316012)
-
(1999)
Cancer Research
, vol.59
, Issue.13
, pp. 3128-3133
-
-
Onizuka, S.1
Tawara, I.2
Shimizu, J.3
Sakaguchi, S.4
Fujita, T.5
Nakayama, E.6
-
13
-
-
34547957665
-
+ regulatory T cells in myelodysplastic syndrome (MDS)
-
DOI 10.1182/blood-2007-01-067546
-
Kordasti, S. Y., W. Ingram, J. Hayden, D. Darling, L. Barber, B. Afzali, G. Lombardi, M. W. Wlodarski, J. P. Maciejewski, F. Farzaneh, and G. J. Mufti. 2007. CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS). Blood 110: 847-850. (Pubitemid 47267420)
-
(2007)
Blood
, vol.110
, Issue.3
, pp. 847-850
-
-
Kordasti, S.Y.1
Ingram, W.2
Hayden, J.3
Darling, D.4
Barber, L.5
Afzali, B.6
Lombardi, G.7
Wlodarski, M.W.8
Maciejewski, J.P.9
Farzaneh, F.10
Mufti, G.J.11
-
14
-
-
33746351730
-
+ regulatory T-cell selection
-
DOI 10.1111/j.0105-2896.2006.00416.x
-
Picca, C. C., J. Larkin, III, A. Boesteanu, M. A. Lerman, A. L. Rankin, and A. J. Caton. 2006. Role of TCR specificity in CD4+ CD25+ regulatory T-cell selection. Immunol. Rev. 212: 74-85. (Pubitemid 44116701)
-
(2006)
Immunological Reviews
, vol.212
, pp. 74-85
-
-
Picca, C.C.1
Larkin III, J.2
Boesteanu, A.3
Lerman, M.A.4
Rankin, A.L.5
Caton, A.J.6
-
15
-
-
77952754636
-
Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO
-
Booth, N. J., A. J. McQuaid, T. Sobande, S. Kissane, E. Agius, S. E. Jackson, M. Salmon, F. Falciani, K. Yong, M. H. Rustin, et al. 2010. Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO. J. Immunol. 184: 4317-4326.
-
(2010)
J. Immunol.
, vol.184
, pp. 4317-4326
-
-
Booth, N.J.1
McQuaid, A.J.2
Sobande, T.3
Kissane, S.4
Agius, E.5
Jackson, S.E.6
Salmon, M.7
Falciani, F.8
Yong, K.9
Rustin, M.H.10
-
16
-
-
24944583626
-
Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics
-
DOI 10.1038/ni1240, PII N1240
-
Bromley, S. K., S. Y. Thomas, and A. D. Luster. 2005. Chemokine receptor CCR7 guides T cell exit from peripheral tissues and entry into afferent lymphatics. Nat. Immunol. 6: 895-901. (Pubitemid 43090444)
-
(2005)
Nature Immunology
, vol.6
, Issue.9
, pp. 895-901
-
-
Bromley, S.K.1
Thomas, S.Y.2
Luster, A.D.3
-
17
-
-
34447277626
-
+ T cells
-
DOI 10.1084/jem.20070322
-
Hikono, H., J. E. Kohlmeier, S. Takamura, S. T. Wittmer, A. D. Roberts, and D. L. Woodland. 2007. Activation phenotype, rather than central- or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells. J. Exp. Med. 204: 1625-1636. (Pubitemid 47048029)
-
(2007)
Journal of Experimental Medicine
, vol.204
, Issue.7
, pp. 1625-1636
-
-
Hikono, H.1
Kohlmeier, J.E.2
Takamura, S.3
Wittmer, S.T.4
Roberts, A.D.5
Woodland, D.L.6
-
18
-
-
0035937587
-
Preferential localization of effector memory cells in nonlymphoid tissue
-
DOI 10.1126/science.1058867
-
Masopust, D., V. Vezys, A. L. Marzo, and L. Lefrancois. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291: 2413-2417. (Pubitemid 32231804)
-
(2001)
Science
, vol.291
, Issue.5512
, pp. 2413-2417
-
-
Masopust, D.1
Vezys, V.2
Marzo, A.L.3
Lefrancois, L.4
-
19
-
-
0033554726
-
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
-
Sallusto, F., D. Lenig, R. Förster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401: 708-712.
-
(1999)
Nature
, vol.401
, pp. 708-712
-
-
Sallusto, F.1
Lenig, D.2
Förster, R.3
Lipp, M.4
Lanzavecchia, A.5
-
20
-
-
0035920510
-
+immunoregulatory T cells
-
DOI 10.1084/jem.194.4.427
-
Bensinger, S. J., A. Bandeira, M. S. Jordan, A. J. Caton, and T. M. Laufer. 2001. Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J. Exp. Med. 194: 427-438. (Pubitemid 32835039)
-
(2001)
Journal of Experimental Medicine
, vol.194
, Issue.4
, pp. 427-438
-
-
Bensinger, S.J.1
Bandeira, A.2
Jordan, M.S.3
Caton, A.J.4
Laufer, T.M.5
-
21
-
-
0035320679
-
+ regulatory T cells induced by an agonist self-peptide
-
DOI 10.1038/86302
-
Jordan, M. S., A. Boesteanu, A. J. Reed, A. L. Petrone, A. E. Holenbeck, M. A. Lerman, A. Naji, and A. J. Caton. 2001. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2: 301-306. (Pubitemid 33706340)
-
(2001)
Nature Immunology
, vol.2
, Issue.4
, pp. 301-306
-
-
Jordan, M.S.1
Boesteanu, A.2
Reed, A.J.3
Petrone, A.L.4
Holenbeck, A.E.5
Lerman, M.A.6
Naji, A.7
Caton, A.J.8
-
22
-
-
9244244736
-
Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells
-
DOI 10.1084/jem.20041022
-
van Santen, H. M., C. Benoist, and D. Mathis. 2004. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 200: 1221-1230. (Pubitemid 39552564)
-
(2004)
Journal of Experimental Medicine
, vol.200
, Issue.10
, pp. 1221-1230
-
-
Van Santen, H.-M.1
Benoist, C.2
Mathis, D.3
-
23
-
-
33745861720
-
Divergent generation of heterogeneous memory CD4 T cells
-
Moulton, V. R., N. D. Bushar, D. B. Leeser, D. S. Patke, and D. L. Farber. 2006. Divergent generation of heterogeneous memory CD4 T cells. J. Immunol. 177: 869-876. (Pubitemid 44036587)
-
(2006)
Journal of Immunology
, vol.177
, Issue.2
, pp. 869-876
-
-
Moulton, V.R.1
Bushar, N.D.2
Leeser, D.B.3
Patke, D.S.4
Farber, D.L.5
-
24
-
-
79955949689
-
Th17 and Foxp3(+) T regulatory cell dynamics and distribution in myelodysplastic syndromes
-
Bouchliou, I., P. Miltiades, E. Nakou, E. Spanoudakis, A. Goutzouvelidis, S. Vakalopoulou, V. Garypidou, V. Kotoula, G. Bourikas, C. Tsatalas, and I. Kotsianidis. 2011. Th17 and Foxp3(+) T regulatory cell dynamics and distribution in myelodysplastic syndromes. Clin. Immunol. 139: 350-359.
-
(2011)
Clin. Immunol.
, vol.139
, pp. 350-359
-
-
Bouchliou, I.1
Miltiades, P.2
Nakou, E.3
Spanoudakis, E.4
Goutzouvelidis, A.5
Vakalopoulou, S.6
Garypidou, V.7
Kotoula, V.8
Bourikas, G.9
Tsatalas, C.10
Kotsianidis, I.11
-
25
-
-
0141688283
-
Adoptive-cell-transfer therapy for the treatment of patients with cancer
-
Dudley, M. E., and S. A. Rosenberg. 2003. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat. Rev. Cancer 3: 666-675. (Pubitemid 37328821)
-
(2003)
Nature Reviews Cancer
, vol.3
, Issue.9
, pp. 666-675
-
-
Dudley, M.E.1
Rosenberg, S.A.2
-
26
-
-
0013869541
-
Tumor antigens
-
Klein, G. 1966. Tumor antigens. Annu. Rev. Microbiol. 20: 223-252.
-
(1966)
Annu. Rev. Microbiol.
, vol.20
, pp. 223-252
-
-
Klein, G.1
-
27
-
-
0000834072
-
Immunology of Experimental Tumors
-
Old, L. J., and E. A. Boyse. 1964. Immunology of Experimental Tumors. Annu. Rev. Med. 15: 167-186.
-
(1964)
Annu. Rev. Med.
, vol.15
, pp. 167-186
-
-
Old, L.J.1
Boyse, E.A.2
-
28
-
-
33846485153
-
Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
-
DOI 10.1038/ni1428, PII NI1428
-
Kim, J. M., J. P. Rasmussen, and A. Y. Rudensky. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8: 191-197. (Pubitemid 46152650)
-
(2007)
Nature Immunology
, vol.8
, Issue.2
, pp. 191-197
-
-
Kim, J.M.1
Rasmussen, J.P.2
Rudensky, A.Y.3
-
29
-
-
0036669298
-
CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice: Implications for the nonredundant function of IL-2
-
DOI 10.1016/S1074-7613(02)00367-9
-
Malek, T. R., A. Yu, V. Vincek, P. Scibelli, and L. Kong. 2002. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17: 167-178. (Pubitemid 35245959)
-
(2002)
Immunity
, vol.17
, Issue.2
, pp. 167-178
-
-
Malek, T.R.1
Yu, A.2
Vincek, V.3
Scibelli, P.4
Kong, L.5
-
30
-
-
0037364804
-
Natural versus adaptive regulatory T cells
-
DOI 10.1038/nri1032
-
Bluestone, J. A., and A. K. Abbas. 2003. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3: 253-257. (Pubitemid 37323210)
-
(2003)
Nature Reviews Immunology
, vol.3
, Issue.3
, pp. 253-257
-
-
Bluestone, J.A.1
Abbas, A.K.2
-
31
-
-
4644237613
-
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
-
DOI 10.1038/nm1093
-
Curiel, T. J., G. Coukos, L. Zou, X. Alvarez, P. Cheng, P. Mottram, M. Evdemon-Hogan, J. R. Conejo-Garcia, L. Zhang, M. Burow, et al. 2004. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 10: 942-949. (Pubitemid 39273735)
-
(2004)
Nature Medicine
, vol.10
, Issue.9
, pp. 942-949
-
-
Curiel, T.J.1
Coukos, G.2
Zou, L.3
Alvarez, X.4
Cheng, P.5
Mottram, P.6
Evdemon-Hogan, M.7
Conejo-Garcia, J.R.8
Zhang, L.9
Burow, M.10
Zhu, Y.11
Wei, S.12
Kryczek, I.13
Daniel, B.14
Gordon, A.15
Myers, L.16
Lackner, A.17
Disis, M.L.18
Knutson, K.L.19
Chen, L.20
Zou, W.21
more..
-
32
-
-
16844365788
-
+ regulatory T cells in immunological tolerance to self and non-self
-
DOI 10.1038/ni1178
-
Sakaguchi, S. 2005. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352. (Pubitemid 41716771)
-
(2005)
Nature Immunology
, vol.6
, Issue.4
, pp. 345-352
-
-
Sakaguchi, S.1
-
33
-
-
0035054606
-
Human CD4(+) CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro
-
Stephens, L. A., C. Mottet, D. Mason, and F. Powrie. 2001. Human CD4(+) CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 31: 1247-1254.
-
(2001)
Eur. J. Immunol.
, vol.31
, pp. 1247-1254
-
-
Stephens, L.A.1
Mottet, C.2
Mason, D.3
Powrie, F.4
-
34
-
-
8544281696
-
+ regulatory T cells that traffic through CXCL12/CXCR4 signals
-
DOI 10.1158/0008-5472.CAN-04-1987
-
Zou, L., B. Barnett, H. Safah, V. F. Larussa, M. Evdemon-Hogan, P. Mottram, S. Wei, O. David, T. J. Curiel, and W. Zou. 2004. Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 64: 8451-8455. (Pubitemid 39491786)
-
(2004)
Cancer Research
, vol.64
, Issue.22
, pp. 8451-8455
-
-
Zou, L.1
Barnett, B.2
Safah, H.3
LaRussa, V.F.4
Evdemon-Hogan, M.5
Mottram, P.6
Wei, S.7
David, O.8
Curiel, T.J.9
Zou, W.10
-
35
-
-
13944260193
-
high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer
-
DOI 10.1016/j.jss.2004.10.004
-
Kawaida, H., K. Kono, A. Takahashi, H. Sugai, K. Mimura, N. Miyagawa, H. Omata, A. Ooi, and H. Fujii. 2005. Distribution of CD4+CD25high regulatory T-cells in tumor-draining lymph nodes in patients with gastric cancer. J. Surg. Res. 124: 151-157. (Pubitemid 40269816)
-
(2005)
Journal of Surgical Research
, vol.124
, Issue.1
, pp. 151-157
-
-
Kawaida, H.1
Kono, K.2
Takahashi, A.3
Sugai, H.4
Mimura, K.5
Miyagawa, N.6
Omata, H.7
Ooi, A.8
Fujii, H.9
-
36
-
-
0036721629
-
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
-
Liyanage, U. K., T. T. Moore, H. G. Joo, Y. Tanaka, V. Herrmann, G. Doherty, J. A. Drebin, S. M. Strasberg, T. J. Eberlein, P. S. Goedegebuure, and D. C. Linehan. 2002. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol. 169: 2756-2761. (Pubitemid 34921025)
-
(2002)
Journal of Immunology
, vol.169
, Issue.5
, pp. 2756-2761
-
-
Liyanage, U.K.1
Moore, T.T.2
Joo, H.-G.3
Tanaka, Y.4
Herrmann, V.5
Doherty, G.6
Drebin, J.A.7
Strasberg, S.M.8
Eberlein, T.J.9
Goedegebuure, P.S.10
Linehan, D.C.11
-
37
-
-
16844378685
-
Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma
-
DOI 10.1158/0008-5472.CAN-04-3232
-
Ormandy, L. A., T. Hillemann, H. Wedemeyer, M. P. Manns, T. F. Greten, and F. Korangy. 2005. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res. 65: 2457-2464. (Pubitemid 40490158)
-
(2005)
Cancer Research
, vol.65
, Issue.6
, pp. 2457-2464
-
-
Ormandy, L.1
Hillemann, T.2
Wedemeyer, H.3
Manns, M.P.4
Greten, T.F.5
Korangy, F.6
-
38
-
-
16244393380
-
Compromised lymphocytes infiltrate hepatocellular carcinoma: The role of T-regulatory cells
-
DOI 10.1002/hep.20644
-
Unitt, E., S. M. Rushbrook, A. Marshall, S. Davies, P. Gibbs, L. S. Morris, N. Coleman, and G. J. Alexander. 2005. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 41: 722-730. (Pubitemid 40462933)
-
(2005)
Hepatology
, vol.41
, Issue.4
, pp. 722-730
-
-
Unitt, E.1
Rushbrook, S.M.2
Marshall, A.3
Davies, S.4
Gibbs, P.5
Morris, L.S.6
Coleman, N.7
Alexander, G.J.M.8
-
39
-
-
3142737258
-
high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells
-
Viguier, M., F. Lemaître, O. Verola, M. S. Cho, G. Gorochov, L. Dubertret, H. Bachelez, P. Kourilsky, and L. Ferradini. 2004. Foxp3 expressing CD4+CD25 (high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J. Immunol. 173: 1444-1453. (Pubitemid 38924326)
-
(2004)
Journal of Immunology
, vol.173
, Issue.2
, pp. 1444-1453
-
-
Viguier, M.1
Lemaitre, F.2
Verola, O.3
Cho, M.-S.4
Gorochov, G.5
Dubertret, L.6
Bachelez, H.7
Kourilsky, P.8
Ferradini, L.9
-
40
-
-
1642497640
-
+ Regulatory T Cells and Their Ligands: Implications for Immunotherapy
-
DOI 10.1016/S1074-7613(03)00359-5
-
Wang, H. Y., D. A. Lee, G. Peng, Z. Guo, Y. Li, Y. Kiniwa, E. M. Shevach, and R. F. Wang. 2004. Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 20: 107-118. (Pubitemid 38134298)
-
(2004)
Immunity
, vol.20
, Issue.1
, pp. 107-118
-
-
Wang, H.Y.1
Lee, D.A.2
Peng, G.3
Guo, Z.4
Li, Y.5
Kiniwa, Y.6
Shevach, E.M.7
Wang, R.-F.8
-
41
-
-
14044257258
-
+ regulatory T cells
-
Wang, H. Y., G. Peng, Z. Guo, E. M. Shevach, and R. F. Wang. 2005. Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells. J. Immunol. 174: 2661-2670. (Pubitemid 40279680)
-
(2005)
Journal of Immunology
, vol.174
, Issue.5
, pp. 2661-2670
-
-
Wang, H.Y.1
Peng, G.2
Guo, Z.3
Shevach, E.M.4
Wang, R.-F.5
-
42
-
-
0035874949
-
+ T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer
-
Woo, E. Y., C. S. Chu, T. J. Goletz, K. Schlienger, H. Yeh, G. Coukos, S. C. Rubin, L. R. Kaiser, and C. H. June. 2001. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res. 61: 4766-4772. (Pubitemid 32691889)
-
(2001)
Cancer Research
, vol.61
, Issue.12
, pp. 4766-4772
-
-
Woo, E.Y.1
Chu, C.S.2
Goletz, T.J.3
Schlienger, K.4
Yeh, H.5
Coukos, G.6
Rubin, S.C.7
Kaiser, L.R.8
June, C.H.9
-
43
-
-
33646422454
-
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
-
Yang, Z. Z., A. J. Novak, M. J. Stenson, T. E. Witzig, and S. M. Ansell. 2006. Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 107: 3639-3646.
-
(2006)
Blood
, vol.107
, pp. 3639-3646
-
-
Yang, Z.Z.1
Novak, A.J.2
Stenson, M.J.3
Witzig, T.E.4
Ansell, S.M.5
-
44
-
-
30144444279
-
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
-
DOI 10.1172/JCI25947
-
Dannull, J., Z. Su, D. Rizzieri, B. K. Yang, D. Coleman, D. Yancey, A. Zhang, P. Dahm, N. Chao, E. Gilboa, and J. Vieweg. 2005. Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J. Clin. Invest. 115: 3623-3633. (Pubitemid 43121851)
-
(2005)
Journal of Clinical Investigation
, vol.115
, Issue.12
, pp. 3623-3633
-
-
Dannull, J.1
Su, Z.2
Rizzieri, D.3
Yang, B.K.4
Coleman, D.5
Yancey, D.6
Zhang, A.7
Dahm, P.8
Chao, N.9
Gilboa, E.10
Vieweg, J.11
-
45
-
-
0037093195
-
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the cancer and leukemia group B
-
DOI 10.1200/JCO.2002.04.117
-
Silverman, L. R., E. P. Demakos, B. L. Peterson, A. B. Kornblith, J. C. Holland, R. Odchimar-Reissig, R. M. Stone, D. Nelson, B. L. Powell, C. M. DeCastro, et al. 2002. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J. Clin. Oncol. 20: 2429-2440. (Pubitemid 34525728)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.10
, pp. 2429-2440
-
-
Silverman, L.R.1
Demakos, E.P.2
Peterson, B.L.3
Kornblith, A.B.4
Holland, J.C.5
Odchimar-Reissig, R.6
Stone, R.M.7
Nelson, D.8
Powell, B.L.9
DeCastro, C.M.10
Ellerton, J.11
Larson, R.A.12
Schiffer, C.A.13
Holland, J.F.14
-
46
-
-
33749438404
-
Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion
-
DOI 10.1056/NEJMoa061292
-
List, A., G. Dewald, J. Bennett, A. Giagounidis, A. Raza, E. Feldman, B. Powell, P. Greenberg, D. Thomas, R. Stone, et al; Myelodysplastic Syndrome-003 Study Investigators. 2006. Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion. N. Engl. J. Med. 355: 1456-1465. (Pubitemid 44511560)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.14
, pp. 1456-1465
-
-
List, A.1
Dewald, G.2
Bennett, J.3
Giagounidis, A.4
Raza, A.5
Feldman, E.6
Powell, B.7
Greenberg, P.8
Thomas, D.9
Stone, R.10
Reeder, C.11
Wride, K.12
Patin, J.13
Schmidt, M.14
Zeldis, J.15
Knight, R.16
-
47
-
-
13444256401
-
Efficacy of lenalidomide in myelodysplastic syndromes
-
DOI 10.1056/NEJMoa041668
-
List, A., S. Kurtin, D. J. Roe, A. Buresh, D. Mahadevan, D. Fuchs, L. Rimsza, R. Heaton, R. Knight, and J. B. Zeldis. 2005. Efficacy of lenalidomide in myelodysplastic syndromes. N. Engl. J. Med. 352: 549-557. (Pubitemid 40204668)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.6
, pp. 549-557
-
-
List, A.1
Kurtin, S.2
Roe, D.J.3
Buresh, A.4
Mahadevan, D.5
Fuchs, D.6
Rimsza, L.7
Heaton, R.8
Knight, R.9
Zeldis, J.B.10
-
48
-
-
45149093744
-
Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy
-
Sloand, E. M., C. O. Wu, P. Greenberg, N. Young, and J. Barrett. 2008. Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy. J. Clin. Oncol. 26: 2505-2511.
-
(2008)
J. Clin. Oncol.
, vol.26
, pp. 2505-2511
-
-
Sloand, E.M.1
Wu, C.O.2
Greenberg, P.3
Young, N.4
Barrett, J.5
|